NCT02996773 2025-11-10Haploidentical BMT With Post-Transplant Cyclophosphamide and BendamustineUniversity of ArizonaPhase 1 Completed50 enrolled
NCT01326702 2019-12-16Veliparib, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Relapsed or Refractory Lymphoma, Multiple Myeloma, or Solid TumorsNational Cancer Institute (NCI)Phase 1/2 Completed43 enrolled 18 charts
NCT01110135 2017-05-24Bendamustine Hydrochloride, Etoposide, Dexamethasone, and Filgrastim For Peripheral Blood Stem Cell Mobilization in Treating Patients With Refractory or Recurrent Lymphoma or Multiple MyelomaUniversity of WashingtonPhase 2 Completed43 enrolled 5 charts